Parkman Healthcare Partners as of June 30, 2020
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 79 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Neurocrine Biosciences (NBIX) | 4.2 | $15M | 122k | 122.00 | |
Gw Pharmaceuticals Ads | 4.1 | $15M | 120k | 122.72 | |
Horizon Therapeutics Pub SHS | 4.1 | $15M | 262k | 55.58 | |
Dex (DXCM) | 3.7 | $13M | 33k | 405.41 | |
GenMark Diagnostics | 3.3 | $12M | 800k | 14.71 | |
Humana (HUM) | 3.3 | $12M | 30k | 387.77 | |
Merck & Co (MRK) | 2.7 | $9.7M | 126k | 77.33 | |
Danaher Corporation (DHR) | 2.5 | $8.8M | 50k | 176.84 | |
Axonics Modulation Technolog (AXNX) | 2.4 | $8.5M | 242k | 35.11 | |
UnitedHealth (UNH) | 2.4 | $8.4M | 29k | 294.95 | |
Spdr Ser Tr S&p Biotech Put Option (XBI) | 2.4 | $8.4M | 75k | 111.95 | |
Edwards Lifesciences (EW) | 2.3 | $8.3M | 120k | 69.11 | |
Dicerna Pharmaceuticals | 2.2 | $7.6M | 301k | 25.40 | |
Natera (NTRA) | 2.1 | $7.5M | 150k | 49.86 | |
Xenon Pharmaceuticals (XENE) | 2.1 | $7.4M | 590k | 12.54 | |
Abbvie (ABBV) | 2.1 | $7.4M | 75k | 98.19 | |
Icad Com New (ICAD) | 2.0 | $7.2M | 726k | 9.99 | |
Turning Point Therapeutics I | 2.0 | $7.1M | 110k | 64.59 | |
Charles River Laboratories (CRL) | 2.0 | $7.0M | 40k | 174.35 | |
Catalent | 2.0 | $7.0M | 95k | 73.31 | |
Iqvia Holdings (IQV) | 1.9 | $6.7M | 48k | 141.87 | |
Vericel (VCEL) | 1.9 | $6.6M | 475k | 13.82 | |
Repro-Med Systems (KRMD) | 1.8 | $6.5M | 722k | 8.98 | |
Seattle Genetics | 1.8 | $6.4M | 38k | 169.92 | |
Mersana Therapeutics (MRSN) | 1.6 | $5.9M | 250k | 23.40 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $5.8M | 20k | 290.30 | |
Madrigal Pharmaceuticals (MDGL) | 1.6 | $5.7M | 50k | 113.26 | |
Acceleron Pharma | 1.5 | $5.5M | 58k | 95.27 | |
Alnylam Pharmaceuticals (ALNY) | 1.5 | $5.3M | 36k | 148.12 | |
Itamar Med Sponsored Ads | 1.5 | $5.2M | 281k | 18.60 | |
Silk Road Medical Inc Common | 1.4 | $5.0M | 120k | 41.89 | |
Molecular Templates | 1.3 | $4.7M | 343k | 13.79 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $4.3M | 901k | 4.76 | |
Arcus Biosciences Incorporated (RCUS) | 1.1 | $4.0M | 160k | 24.74 | |
Kadmon Hldgs | 1.0 | $3.7M | 725k | 5.12 | |
Kodiak Sciences (KOD) | 1.0 | $3.5M | 65k | 54.13 | |
Insulet Corporation (PODD) | 1.0 | $3.4M | 18k | 194.29 | |
Novavax Com New (NVAX) | 0.9 | $3.3M | 40k | 83.35 | |
Avrobio Ord (AVRO) | 0.9 | $3.3M | 191k | 17.45 | |
Axsome Therapeutics (AXSM) | 0.9 | $3.3M | 40k | 82.28 | |
Nuance Communications | 0.9 | $3.2M | 125k | 25.31 | |
Immunovant (IMVT) | 0.9 | $3.0M | 125k | 24.35 | |
Stereotaxis Com New (STXS) | 0.8 | $3.0M | 669k | 4.46 | |
Kala Pharmaceuticals | 0.8 | $2.9M | 275k | 10.51 | |
Aclaris Therapeutics (ACRS) | 0.8 | $2.8M | 1.7M | 1.62 | |
Haemonetics Corporation (HAE) | 0.8 | $2.7M | 30k | 89.56 | |
Seaspine Holdings | 0.7 | $2.6M | 246k | 10.47 | |
InfuSystem Holdings (INFU) | 0.7 | $2.5M | 216k | 11.54 | |
Bridgebio Pharma (BBIO) | 0.7 | $2.5M | 75k | 32.61 | |
Trillium Therapeutics Com New | 0.7 | $2.4M | 300k | 8.09 | |
Akero Therapeutics (AKRO) | 0.7 | $2.4M | 95k | 24.92 | |
Karyopharm Therapeutics (KPTI) | 0.6 | $2.3M | 121k | 18.94 | |
Iradimed (IRMD) | 0.6 | $2.2M | 95k | 23.21 | |
Aurinia Pharmaceuticals (AUPH) | 0.6 | $2.1M | 130k | 16.25 | |
Nephros (NEPH) | 0.6 | $2.1M | 251k | 8.39 | |
Alphatec Hldgs Com New (ATEC) | 0.6 | $2.0M | 427k | 4.70 | |
Eidos Therapeutics | 0.6 | $2.0M | 41k | 47.68 | |
Biohaven Pharmaceutical Holding | 0.5 | $1.8M | 25k | 73.12 | |
Misonix | 0.5 | $1.8M | 130k | 13.57 | |
Immunic (IMUX) | 0.5 | $1.7M | 140k | 12.12 | |
Meiragtx Holdings (MGTX) | 0.5 | $1.7M | 135k | 12.52 | |
Aprea Therapeutics | 0.4 | $1.6M | 40k | 38.79 | |
Pieris Pharmaceuticals | 0.4 | $1.4M | 459k | 3.10 | |
Schrodinger (SDGR) | 0.4 | $1.4M | 15k | 91.60 | |
Quidel Corporation | 0.4 | $1.3M | 6.0k | 223.67 | |
Catalyst Biosciences Com New | 0.4 | $1.3M | 215k | 5.87 | |
Rapt Therapeutics (RAPT) | 0.3 | $1.2M | 40k | 29.02 | |
Catabasis Pharmaceuticals In Com New | 0.3 | $1.0M | 156k | 6.43 | |
Mustang Bio | 0.3 | $965k | 303k | 3.18 | |
Mannkind Corp Com New (MNKD) | 0.3 | $964k | 551k | 1.75 | |
Castle Biosciences (CSTL) | 0.3 | $942k | 25k | 37.68 | |
Amarin Corp Spons Adr New (AMRN) | 0.2 | $873k | 126k | 6.92 | |
Peregrine Pharmaceuticals (CDMO) | 0.2 | $821k | 125k | 6.57 | |
Surface Oncology | 0.2 | $820k | 125k | 6.56 | |
Moderna (MRNA) | 0.2 | $642k | 10k | 64.20 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $445k | 30k | 14.83 | |
Apyx Medical Corporation (APYX) | 0.1 | $391k | 71k | 5.55 | |
Marinus Pharmaceuticals | 0.1 | $254k | 100k | 2.54 | |
Clearpoint Neuro (CLPT) | 0.0 | $89k | 25k | 3.55 |